Drug recall · January 22, 2014
FEBUXOSTAT Tablet recall
Why: Labeling: Label Mixup; FEBUXOSTAT Tablet, 40 mg may be potentially mislabeled as methylPREDNISolone, Tablet, 4 mg, NDC 59746000103, Pedigree: AD21811_17, EXP: 5/1/2014; tiZANidine HCl, Tablet, 2 mg, NDC 55111017915, Pedigree: W002663, EXP: 6/5/2014; SODIUM CHLORIDE, Tablet, 1000 mg, NDC 00527111610, Pedigree: W003926, EXP: 7/1/2014.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
FEBUXOSTAT Tablet, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 64764091830
- Lots / codes
FEBUXOSTAT Tablet, 40 mg has the following codes Pedigree: AD23082_16, EXP: 11/1/2013; Pedigree: W002664, EXP: 6/5/2014; Pedigree: W003927, EXP: 7/1/2014.
- Quantity
- 300 Tablets
- Company
- Aidapak Services, LLC, Vancouver, WA
- Distribution
- Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
- Initiated
- July 2, 2013 · Voluntary: Firm initiated
- Classified
- January 16, 2014
- Reported
- January 22, 2014
- Ended
- February 7, 2014
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Febuxostat
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.